-
-
Call more information
660-596-2224 -
ASA Monitor August 2024, Vol. 88, 30. Benefits of rapid treatment against opioid use disorder An NIH-supported clinical trial indicates that starting extended-release naltrexone (XR-naltrexone) within five to seven days of patients seeking treatment for opioid use disorder is more effective than the conventional 10-15 day period. Traditionally, XR-naltrexone treatment necessitates a seven- to 10-day opioid-free […]
Read MoreAuthors: Jennifer A. Rock-Klotz, MBA; Thomas R. Miller, PhD, MBA ASA Monitor August 2024, Vol. 88, 1–5. ASA’s Center for Anesthesia Workforce Studies (CAWS) reports trends in anesthesiology resident matches based on the National Resident Matching Program (NRMP) Results and Data report published in May or June each year (asamonitor.pub/2Sm1t96). This report summarizes data on candidates who […]
Read MoreWe are seeking a dedicated anesthesiologist to join our all-anesthesiologist group. Our team will consist of 4 full-time providers and 1 for vacation relief, managing 3 operating rooms. Position Highlights: Zero call for 3 weeks, followed by 1 week of call without daytime work only call after 7 PM therefore you may not work the […]
Read MoreAuthors: Duarte F F, Dias N M Cureus 16(8): e65940. Abstract Myelomeningocele (MMC) is an in-utero closure defect of the posterior portion of the neural tube, and it is the most common neural tube defect (NTD) compatible with life. It is usually associated with other congenital malformations, such as hydrocephalus and Chiari type 2 syndrome. […]
Read MoreAuthors: Mei Li, M.D. et al Anesthesiology July 2024. Background As a mechanosensitive cation channel and key regulator of vascular barrier function, endothelial transient receptor potential vanilloid-type 4 (TRPV4) contributes critically to ventilator-induced lung injury (VILI) and edema formation. Ca2+ influx via TRPV4 can activate Ca2+-activated K + (KCa) channels, categorized into small (SK1-3), intermediate (IK1), and big […]
Read More